Clinical hepatology: Profile of an urban, hospital-based practice

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 813-815

  Byron, Dawn ^a   Minuk, Gerald Y ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHRONIC HEPATITIS; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; SEX RATIO;

EID: 16044363694     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855181     Document Type: Article

References (14)

1. Centers for Disease Control. Advance report of final mortality statistics, 1989: Monthly Vital Statistics Report 1992;40(suppl 2):1-51.
2. Katz ME, Holmes MD, Power KL, Wise PH. Mortality rates among 15- to 44-year old women in Boston: looking beyond reproductive status. Am J Public Health 1995;85:1135-1138.
3. National Institutes of Health Consensus Conference Statement: Liver transplantation - June 20-23, 1983. HEPATOLOGY 1983:(suppl)107S-110S.
4. Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987; 317:1421-1427.
5. Lindor KD, Hoofnagle J, Maddrey WC, MacKay IR, Dickson ER. Primary biliary cirrhosis clinical research single-topic conference. HEPATOLOGY 1996;23:639-644.
6. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994;69:969-982.
7. Zhang M, Song G, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E and ciprofloxacin on cirrhosis in the rat. Gastroenterology 1996;110:1150-1155.
8. Thomson AD, Bird GLA, Saunder JB. Alcoholic liver disease. Gut 1991; (suppl):97-103.
9. Hisnanick JJ. Forecasting the demand for inpatient services for specific chronic conditions. J Med Syst 1994;18:9-21.
10. Reich T. Biologic-marker studies in alcoholism. N Engl J Med 1988;318: 180-182.
11. Sloan FA, Reilly BA, Schenzler C. Effects of prices, civil and criminal sanctions, and law enforcement on alcohol-related mortality. J Stud Alcohol 1994;55:454-465.
12. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrilo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 1989;321:1501-1506.
13. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, et al. A randomized, controlled trial of interferon alfa-2b, alone and following prednisone withdrawal, in the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
14. Wong WWS, Minuk GY. A cross-sectional seroepidemiologic survey of chronic hepatitis B virus infections in Southeast Asian immigrants residing in a Canadian urban centre. Clin Invest Med 1994;17:443-447.